Advanced search
Publication Cover
Journal of Blood Medicine Volume 9, 2018 - Issue
Submit an article Journal homepage
102
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment

Majed S Al Yami1 Department of Pharmacy Practice, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;2 Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA
,
Sawsan Kurdi2 Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;3 Department of Pharmacy Practice, University of Dammam, Dammam, Saudi Arabia
&
Ivo Abraham2 Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;4 Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA;5 Department of Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USACorrespondence[email protected]
Pages 25-34 | Published online: 21 Feb 2018

References

  • HeitJASpencerFAWhiteRHThe epidemiology of venous thromboembolismJ Thromb Thrombolysis201641131426780736
  • AminANVarkerHPrincicNLinJThompsonSJohnstonSDuration of venous thromboembolism risk across a continuum in medically ill hospitalized patientsJ Hosp Med20127323123822190427
  • KahnSRLimWDunnASPrevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest20121412 Supple195Se226S22315261
  • HullRDSchellongSMTapsonVFExtended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trialAnn Intern Med2010153181820621900
  • GoldhaberSZLeizoroviczAKakkarAKApixaban versus enoxaparin for thromboprophylaxis in medically ill patientsN Engl J Med2011365232167217722077144
  • CohenATSpiroTEBüllerHRRivaroxaban for thromboprophylaxis in acutely ill medical patientsN Engl J Med2013368651352323388003
  • CohenATHarringtonRAGoldhaberSZExtended thromboprophylaxis with betrixaban in acutely ill medical patientsN Engl J Med2016375653454427232649
  • CurtinFSchulzPAssessing the benefit: risk ratio of a drug – randomized and naturalistic evidenceDialogues Clin Neurosci201113218319021842615
  • TaoDBienJDeLougheryTShatzelJExtended thromboprophylaxis with direct oral anticoagulants for medical patients: a systematic review and meta-analysisBlood2017129565365527998890
  • LiewAYPiranSEikelboomJWDouketisJDExtended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trialsJ Thromb Thrombolysis201743329130127900627
  • Falck-YtterYFrancisCWJohansonNAPrevention of VTE in orthopedic surgery patientsChest20121412 Supple278Se325S22315265
  • RaskobGESpyropoulosACZrubekJThe MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implicationsThromb Haemost201611561240124826842902

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.